home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/bb6c6a54-3a31-47dd-a4ec-b6fe43118283_Whitepaper_Bionity2019_Pharmaindustrie_EN[1].pdf
whitepaper
SHARESHARESHARE
WHY DRUG MANUFACTURING NEEDS TO BECOME MORE FLEXIBLE
Digital transformation does not stop at the pharmaceutical industry. But until Pharma 4.0 can become socially acceptable, it will first and foremost be necessary to define globally uniform standards. This is going to take time. Time which the industry does not have in view of the speed of development at Google and Amazon and their penetration of the healthcare market. The White Paper gives a brief overview of the way in which structures have evolved over time and places them in the context of current technological developments in drug production. DOWNLOAD